Education
About Us
Working with TipRanks
Follow Us
Bionano Genomics (BNGO)
NASDAQ:BNGO
| Mar 25 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 30.78M | $ 36.12M | $ 27.80M | $ 17.98M | $ 8.50M |
| Gross Profit | $ 380.00K | $ 9.57M | $ 5.95M | $ 3.87M | $ 2.77M |
| Operating Income | $ -103.98M | $ -215.25M | $ -131.70M | $ -77.10M | $ -38.55M |
| EBITDA | $ -97.47M | $ -213.60M | $ -120.31M | $ -73.86M | $ -35.57M |
| Net Income | $ -112.02M | $ -232.49M | $ -132.60M | $ -72.44M | $ -41.11M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 9.47M | $ 66.77M | $ 113.19M | $ 250.61M | $ 38.45M |
| Total Assets | $ 76.67M | $ 214.40M | $ 307.50M | $ 377.10M | $ 60.45M |
| Total Debt | $ 27.30M | $ 79.41M | $ 11.67M | $ 10.70M | $ 16.32M |
| Net Debt | $ 18.12M | $ 61.47M | $ 6.58M | $ -13.88M | $ -22.12M |
| Total Liabilities | $ 41.30M | $ 118.25M | $ 58.10M | $ 39.98M | $ 25.37M |
| Stockholders' Equity | $ 35.38M | $ 96.16M | $ 249.40M | $ 337.12M | $ 35.08M |
| Cash Flow | |||||
| Free Cash Flow | $ -69.03M | $ -126.87M | $ -128.12M | $ -73.39M | $ -38.31M |
| Operating Cash Flow | $ -68.92M | $ -125.18M | $ -124.82M | $ -71.93M | $ -38.31M |
| Investing Cash Flow | $ 73.84M | $ 24.16M | $ 82.77M | $ -278.06M | $ -2.45M |
| Financing Cash Flow | $ -13.69M | $ 113.81M | $ 23.01M | $ 336.11M | $ 61.90M |
BioNano Genomics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.